我们的伦敦律师拥有处理大麻相关业务各个方面的第一手经验。作为英国大麻监管的领先权威，我们就医用大麻 (CBPM) 和 CBD 健康市场为客户提供建议。
You, Cannabis
& Ince, in any case
英国现在是欧洲领先的合法大麻市场。英国的 CBD 健康市场是仅次于美国的全球第二大市场。 英士的伦敦律师拥有处理大麻相关业务各个方面的第一手经验。 英士在欧洲、中东和亚洲设有办事处，可以很好地为快速发展的欧洲工业和新兴市场提供服务。
2018 年，英国政府将基于大麻的医疗用途产品的处方合法化 - 称为 CBPM。大麻公司现在有一条清晰的合规路线，允许它们在伦敦证券交易所上市。英国大麻行业已成为主流，机构投资者、制药集团和全球消费品牌都活跃在该行业。
我们的专业领域
在英士，我们位于伦敦的监管和公司律师 顾问可以就以下方面提供建议：
- 产品合规性和配方
- 导入/导出最佳实践
- 医疗器械审批
- 投资该行业的 POCA 合规性
- 新型食品合规性
- 大麻企业的企业并购
- 资本市场建议和代表
- 知识产权和商标
- 种植许可证申请
- 管制药品许可证申请
- 迷幻药
- 医疗保健和健康技术监管提交
- Covid-19 相关监管批准。
我们如何提供帮助
作为英国大麻法规的首要权威，我们位于伦敦的律师在处理大麻相关业务的各个方面拥有第一手经验。 英士就公司许可和监管提交向MHRA，CQC，The Home Office，Border Force 和 Food Standards Agency 提供建议。
除监管机构外，我们还与该行业内的组织建立了协会，例如Volteface，AlphaGreen，Bloompoint 和 Agri-TechE，我们的律师在他们的活动中发言并提供文章和评论。
其他相关服务
我们的法律专家曾就许多与大麻相关的 IPO、并购交易和知识产权事宜提供咨询。我们 拥有支持大麻部门的既定服务网络，例如，banking solutions，shipping agents 和 business insurance。我们可以为您提供大麻企业可能需要的额外服务。
Case Studies
Director of CBD company accused of cannabis supply and importation
The director of a CBD company was accused of cannabis supply and importation, notably relating to the hemp or CBD flower. At trial, Counsel was able to secure his acquittal on the supply count, based on Section 28 of the Misuse of Drugs Act 1971 defence, that he did not know, suspect or have reason to suspect this was a controlled drug. Following acquittal, the prosecution did not proceed on the importation count. Our client was acquitted on all counts.
主要联系人
新闻和见解— 大麻
新闻 / First-Ever Pan-European Public Opinion Poll on Cannabis Finds a Continent Ready for Legalisation
07-04-2022 /
A Report Backed by New Polling Data and Contributions from Top Cannabis Executives Finds That More Than Half of Europeans Support Adult-Use Cannabis Legalisation.
新闻 / CBD and Novel Foods: ACI provides more information
05-03-2020 /
More information on how the FSA Novel Food application procedure is going to work has been provided by the ACI. In particular they have provided further clarity on the application timetable and the likely cost burden on SMEs.
洞察力 / CBD and Novel Foods – The Devil is in the Detail
19-02-2020 /
The Novel Food announcement by the FSA landed last week and created major waves in the CBD world. By then we had all been waiting on this guidance from the regulator for a long time. It wasn’t the announcement that I would have wanted, but like Brexit, whether you were for it or against it, it has happened. At this point in time, any kind of clarity is welcome. Now we await the formal protocols of the application process but there is enough information around for us to start getting into the detail.
订阅电子通讯
所有标有*的字段都是必填的